UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000060642 |
|---|---|
| Receipt number | R000068578 |
| Scientific Title | Feasibility Study of Right Subphrenic Cytology Assessment during Robot-Assisted Surgery for Endometrial Cancer |
| Date of disclosure of the study information | 2026/03/01 |
| Last modified on | 2026/02/10 12:52:39 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Feasibility Study of Right Subphrenic Cytology Assessment during Robot-Assisted Surgery for Endometrial Cancer
Acronym
Feasibility Study of Right Subphrenic Cytology Assessment during Robot-Assisted Surgery for Endometrial Cancer
Scientific Title
Feasibility Study of Right Subphrenic Cytology Assessment during Robot-Assisted Surgery for Endometrial Cancer
Scientific Title:Acronym
Feasibility Study of Right Subphrenic Cytology Assessment during Robot-Assisted Surgery for Endometrial Cancer
Region
| Japan |
Condition
Condition
Endometrial carcinoma
Classification by specialty
| Obstetrics and Gynecology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The aim of this study is to evaluate whether right subphrenic cytology can be safely and reliably performed during robot-assisted surgery for patients with endometrial cancer, and whether specimens of sufficient quality for pathological diagnosis can be obtained
Basic objectives2
Others
Basic objectives -Others
The aim of this study is to evaluate whether right subphrenic cytology can be safely and reliably performed during robot-assisted surgery for patients with endometrial cancer, and whether specimens of sufficient quality for pathological diagnosis can be obtained
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Pathological Evaluability Rate of Right Subphrenic Cytology
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Diagnosis
Type of intervention
| Maneuver |
Interventions/Control_1
Right subphrenic cytology will be uniformly added for all cases.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
1) Diagnosed with endometrial cancer preoperatively
2) Scheduled to undergo robot-assisted surgery
3) Provided written informed consent to participate in this study
4) Age 18 years or older at the time of consent
Key exclusion criteria
1) Patients deemed inappropriate for inclusion in this study by the attending physician
2) Patients with uterine sarcoma
3) Patients who have received preoperative chemotherapy
4) Women who are pregnant or may be pregnant
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Takanori |
| Middle name | |
| Last name | Yokoyama |
Organization
NHO Shikoku Cancer Center
Division name
Gynecology
Zip code
791-0280
Address
Ko-160 Minami-Umemoto, Matsuyama, Ehime, Japan
TEL
089-999-1111
yokoyama.takanori.dk@mail.hosp.go.jp
Public contact
Name of contact person
| 1st name | Takanori |
| Middle name | |
| Last name | Yokoyama |
Organization
NHO Shikoku Cancer Center
Division name
Gynecology
Zip code
7910280
Address
Ko-160 Minami-Umemoto, Matsuyama, Ehime, Japan
TEL
089-999-1111
Homepage URL
yokoyama.takanori.dk@mail.hosp.go.jp
Sponsor or person
Institute
National Hospital Organization (NHO) Shikoku Cancer Center
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Hospital Organization (NHO) Shikoku Cancer Center
Address
Ko-160 Minami-Umemoto, Matsuyama, Ehime, Japan
Tel
089-999-1111
yokoyama.takanori.dk@mail.hosp.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 03 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 12 | Month | 02 | Day |
Date of IRB
Anticipated trial start date
| 2026 | Year | 03 | Month | 01 | Day |
Last follow-up date
| 2030 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 02 | Month | 10 | Day |
Last modified on
| 2026 | Year | 02 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068578
